[1] Wang, K.; Zhao, Y.; Cao, X. Global burden and future trends in psoriasis epidemiology: insights from the global burden of disease study 2019 and predictions to 2030. Arch. Dermatol. Res. 2024,316(4),114. https://doi.org/10.1007/s00403-024-02846-z
[2] Rapalli, V.K.; Singhvi, G.; Dubey, S.K.; Gupta, G.; Chellappan, D.K.; Dua, K. Emerging landscape in psoriasis management: From topical application to targeting biomolecules. Biomed. Pharmacother. 2018,106,707-713. https://doi.org/10.1016/j.biopha.2018.06.136
[3] Lowes, M.A.; Suárez-Fariñas, M.; Krueger, J.G. Immunology of psoriasis. Annu. Rev. Immunol. 2014,32,227-255. https://doi.org/10.1146/annurev-immunol-032713-120225
[4] Patient information leaflet of Desonide cream & Lotion (Desowen) available at https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a7e5f030-b849-4805-94e6-f45631eaa37f
[5] Ma, Q.; Zhang, J.; Lu, B.; Linm H.; Sarkar, R.; Wu, T.; Li, X. Nanoemulgel for Improved Topical Delivery of Desonide: Formulation Design and Characterization. AAPS PharmSciTech. 2021,22,163. https://doi.org/10.1208/s12249-021-02035-5
[6] Uva, L.; Miguel, D.; Pinheiro, C.; Antunes, J.; Cruz, D.; Ferreira, J.; Filipe, P. Mechanisms of action of topical corticosteroids in psoriasis. Int. J. Endocrinol. 2012,2012(1), 561018. https://doi.org/10.1155/2012/561018
[7] Sharma, K; Sapra, B; Kant, S; Bedi, N. Formulation and Evaluation of Desonide Loaded Microemulsion Based Gel for Management of Atopic Dermatitis. J. Nanomed. 2021,4(1),1035.
[8] Zhang, J.; Yao, Y.; Liu, H.; Ma, Q.; Huang, L.; Chen, Y.; Lin, H. Desonide Nanoemulsion Gel for Transdermal Absorption Drug Delivery: Pharmacodynamic and Safety Evaluation. Curr. Drug Deliv. 2023,20(10),1525-1532. https://doi.org/10.2174/1567201819666220819110128
[9] Seenivasan, K.; Priyadharshini, R.; Barish; Mahalakshmi, S. Formulation and evaluation of desonide ethosomal gel. Int. J. Res. Pharm and Pharm Sci. 2024,9(3),49-53.
[10] Antonow, M.B.; Lorenzoni, R.; Barbosa, G.M.; Ourique, A.F.; Gomes, P.; Raffin, R.P. Development and Physicochemical Characterization of Desonide-Loaded Nanocapsule Suspensions. Adv. Mater. Sci. Eng. 2016,2016,7395896. http://dx.doi.org/10.1155/2016/7395896
[11] Rosa, P.; Friedrich, M.L.; dos Santos, J.; Pegoraro, N.S.; Camponogara, C.; Oliveira, S.M.; Adams, A.I.H.; de Bona da Silva, C. Development of a nanotechnological hydrogel containing desonide nanocapsules in association with acai oil: design and in vivo evaluation. Pharm. Dev. Technol. 2022,27(6),654–664. https://doi.org/10.1080/10837450.2022.2103147
[12] Todke, P.; Shah, V.H. Psoriasis: implication to disease and therapeutic strategies, with an emphasis on drug delivery approaches. Int. J. Dermatol. 2018,57(11),1387–1402. https://doi.org/10.1111/ijd.14047
[13] Cerqueira-Coutinho, C.; Dos Santos, E.P.; Mansur, C.R. Niosomes as Nano-Delivery Systems in the Pharmaceutical Field. Crit. Rev. Ther. Drug Carrier Syst. 2016,33(2),195–212. https://doi.org/10.1615/CritRevTherDrugCarrierSyst.2016016167
[14] Zaid Alkilani, A.; Hamed, R.; Abdo, H.; Swellmeen, L.; Basheer, H.A.; Wahdan, W.; Abu Kwiak A.D. Formulation and Evaluation of Azithromycin-Loaded Niosomal Gel: Optimization, In Vitro Studies, Rheological Characterization, and Cytotoxicity Study. ACS Omega. 2022,7(44),39782-39793.https://doi.org/10.1021/acsomega.2c03762
[15] Patel, K.K.; Kumar, P.; Thakkar, H.P. Formulation of Niosomal Gel for Enhanced Transdermal Lopinavir Delivery and Its Comparative Evaluation with Ethosomal Gel. AAPS PharmSciTech. 2012,13,1502–1510. https://doi.org/10.1208/s12249-012-9871-7
[16] Matlapudi, M.S.; Areti, A.R. Formulation and Evaluation of Desonide Loaded Niosomes Prepared by Film Hydration Technique Using Box-Behnken Design. in Current Trends in Drug Discovery, Development and Delivery (CTD4-2022), ed. M. Murahari, B. N. Nalluri, and G. Chakravarthi, Royal Society of Chemistry. 2023,358,351-360. https://doi.org/10.1039/9781837671090-00351
[17] Pandey, S.S.; Shah, K.M.; Maulvi, F.A.; Desai, D.T.; Gupta, A.; Joshi, S.V.; Shah, D.O. Topical delivery of cyclosporine loaded tailored niosomal nanocarriers for improved skin penetration and deposition in psoriasis: Optimization, ex vivo and animal studies. J. Drug Deliv. Sci. Technol. 2021,63,102441.https://doi.org/10.1016/j.jddst.2021.102441
[18] Soni, S.; Baghel. K.; Soni. M.L.; Kashaw. S.K.; Soni, V. Size-dependent effects of niosomes on the penetration of methotrexate in skin layers. Futur. J. Pharm. Sci. 2024,10(48),1-18. http://doi.org/10.1186/s43094-024-00624-2
[19] Qiu, F.; Xi, L.; Chen, S.;l Zhao, Y.; Wang, Z.; Zheng, Y. Celastrol Niosome Hydrogel Has Anti-Inflammatory Effect on Skin Keratinocytes and Circulation without Systemic Drug Exposure in Psoriasis Mice. Int. J. Nanomedicine. 2021,16,6171-6182. https://doi.org/10.2147/IJN.S323208
[20] El-Say, K.M.; Abd-Allah, F.I.; Lila, A.E.; Hassan Ael-,S.; Kassem, A.E. Diacerein niosomal gel for topical delivery: development, in vitro and in vivo assessment. J. Liposome Res. 2016,26(1),57-68. https://doi.org/10.3109/08982104.2015.1029495
[21] Matlapudi, M.S.; Areti, A.R.; Jaiswal, Y.; Bantal, V.; Medishetti, R. Enhancing topical drug delivery of Apremilast through niosomal gel formulation: Ex vivo skin permeation and in vivo evaluation for psoriasis. Thai J. Pharm. Sci. 2025,49(1),3. https://doi.org/10.56808/3027-7922.2978
[22] Sathe, P.; Saka, R.; Kommineni, N.; Raza, K.; Khan, W. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model. Drug Dev. Ind. Pharm. 2019,45(5),826–838. https://doi.org/10.1080/03639045.2019.1576722
[23] Obeid, M.A.; Khadra, I.; Aljabali, A.A.A.; Amawi, H.; Ferro, V.A. Characterisation of niosome nanoparticles prepared by microfluidic mixing for drug delivery. Int. J. Pharm. X. 2022,4,100137. https://doi.org/10.1016/j.ijpx.2022.100137
[24] Gouda, R.; Baishya, H.; Qing, Z. Application of Mathematical Models in Drug Release Kinetics of Carbidopa and Levodopa ER Tablets. J. Develop. Drugs. 2017,6(2),1-8. https://doi.org/10.4172/2329-6631.1000171
[25] Mahdavi Moghddam, S.R.; Ahad, A; Aqil, M; Imam, S.S.; Sultana, Y. Formulation and optimization of niosomes for topical diacerein delivery using 3-factor, 3-level Box-Behnken design for the management of psoriasis. Mater. Sci. Eng. C. 2016,69,789–797. https://doi.org/10.1016/j.msec.2016.07.043
[26] Bhardwaj, P.; Tripathi, P.; Pandey, S.; Gupta, R.; Patil, P.R. Cyclosporine and Pentoxifylline laden tailored niosomes for the effective management of psoriasis: In-vitro optimization, Ex-vivo and animal study. Int. J. Pharm. 2022,626,122143. https://doi.org/10.1016/j.ijpharm.2022.122143
[27] Fadaei, M.S.; Fadaei, M.R.; Kheirieh, A.E.; Rahmanian-Devin, P.; Dabbaghi, M.M.; Nazari Tavallaei, K.; Shafaghi, A.; Hatami, H.; Baradaran Rahimi, V.; Nokhodchi, A.; Askari, V.R. Niosome as a promising tool for increasing the effectiveness of anti-inflammatory compounds. EXCLI J. 2024,23,212-263. https://doi.org/10.17179/excli2023-6868
[28] Neu, S.D.; Strzepa, A.; Martin, D.; Sorci-Thomas, M.G.; Pritchard, K.A.Jr; Dittel, B.N. Myeloperoxidase Inhibition Ameliorates Plaque Psoriasis in Mice. Antioxidants. 2021,10(9),1338. https://doi.org/10.3390/antiox10091338
[29] Guo, J.W.; Cheng, Y.P.; Liu, C.Y.; Thong, H.Y.; Huang, C.J.; Lo, Y.; Wu, C.Y.; Jee, S.H. Salvianolic Acid B in Microemulsion Formulation Provided Sufficient Hydration for Dry Skin and Ameliorated the Severity of Imiquimod-Induced Psoriasis-Like Dermatitis in Mice. Pharmaceutics. 2020, 12(5), 457. https://doi.org/10.3390/pharmaceutics12050457
[30] Xu, Y.; Shi, Y.; Huang, J.; Gu, H.; Li, C.; Zhang, L.; Liu, G.; Zhou, W.; Du, Z. The Essential Oil Derived from Perilla frutescens (L.) Britt. Attenuates Imiquimod-Induced Psoriasis-like Skin Lesions in BALB/c Mice. Molecules. 2022,27(9),2996. https://doi.org/10.3390/molecules27092996